Integrated Strategies for Enhanced Cordycepin Production from Cordyceps militaris: Biosynthetic Regulation to Translational Applications
Pharmaceuticals · 16.11.2026 · 19 (11) · 1822
DOI: 10.3390/ph19111822 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 16.11.2026. Verfasst von Divya Singh und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Cordyceps militaris offers a cultivable source of cordycepin, a pharmaceutically relevant nucleoside. This review integrates evidence on cultivation, cordycepin biosynthesis and regulation, artificial intelligence and omics applications, recovery, and biological activities, with emphasis on reproducible production and pharmaceutical development. Solid-state and submerged cultivation serve different production targets; however, cordycepin yield and product quality vary with strain, substrate, developmental stage, and process conditions. Cordycepin production depends on biosynthetic activity and protection against deamination associated with the cns1–cns4 cluster, precursor supply, and environmental regulation rather than on gene expression alone. Genetic engineering, metabolic modelling, multi-omics, machine learning, and process monitoring have supported production improvement, pathway analysis or prediction, but these approaches remain poorly integrated. The reviewed studies do not demonstrate validated online cordycepin estimation or autonomous control. Recovery methods involve trade-offs among yield, purity, cost, and throughput, highlighting the need for consistent product specifications. Cordycepin shows anticancer, anti-inflammatory, and antioxidant activities, although evidence remains preclinical and limited by variable experimental exposures, incomplete mechanistic validation, and insufficient pharmacokinetic and clinical data. Future progress requires standardized strains and cultivation protocols, causal metabolic validation, externally validated predictive models, integrated process control, scalable recovery, and translational evaluation.
Zitieren
APA
Singh, D., Luxmi, V., Gaurav, H., Yadav, D., Tripathi, S., Shukla, A. C., Kumar, P., Jamal, Q. M. S., & Ahmad, K. (2026). Integrated Strategies for Enhanced Cordycepin Production from Cordyceps militaris: Biosynthetic Regulation to Translational Applications. Pharmaceuticals, 19(11), 1822. https://doi.org/10.3390/ph19111822
Vancouver
Singh D, Luxmi V, Gaurav H, Yadav D, Tripathi S, Shukla AC, et al. Integrated Strategies for Enhanced Cordycepin Production from Cordyceps militaris: Biosynthetic Regulation to Translational Applications. Pharmaceuticals. 2026;19(11):1822. doi:10.3390/ph19111822
BibTeX
@article{Singh2026,
author = {Singh, Divya and Luxmi, Vijay and Gaurav, Harshita and Yadav, Divyanshu and Tripathi, Shiva and Shukla, Amritesh Chandra and Kumar, Pradeep and Jamal, Qazi Mohammad Sajid and Ahmad, Khurshid},
title = {Integrated Strategies for Enhanced Cordycepin Production from Cordyceps militaris: Biosynthetic Regulation to Translational Applications},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {11},
pages = {1822},
doi = {10.3390/ph19111822}
}
EUVIMED